Skip to main content
Premium Trial:

Request an Annual Quote

Wasatch Microfluidics Raising $1M

NEW YORK (GenomeWeb News) – Wasatch Microfluidics is in the process of raising $1 million in a Series B round that is expected to close within the next three weeks, its president said.

Earlier this week, Pasadena Angels announced it had invested $475,000 in the round, and today Wasatch President Josh Eckman told GenomeWeb Daily News that the financing will be used primarily to build up the firm's sales and marketing operations.

Pasadena, an investment group based in Pasadena, Calif., added that the funding will also go toward a turnkey solution that combines Wasatch's protein printing technology with a surface plasmon resonance biosensor and toward moving the platform technology closer to a multiple product line.

The other investors in the round are made up of angel investors, Eckman said. The company raised $260,000 in a Series A round in 2007.

Based in Salt Lake City, Wasatch was founded in 2005 and licensed technology from the University of Utah called Continuous Flow Microspotter for depositing biomolecules on biosensor surfaces.

According to Wasatch's website, CFM "uses flow to cycle molecules back and forth over the surface, yielding optimal binding from crude or dilute solutions," resulting in 10,000-fold enhancements in sensitivity and printing at concentrations 1,000-fold more dilute than other technologies.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.